Titlebook: Handbook of Anticancer Pharmacokinetics and Pharmacodynamics; William D. Figg,Howard L. McLeod Book 20041st edition Humana Press 2004 DNA.

只看該作者 · 發(fā)表于 2025-3-28 20:05:11

Intrathecal Chemotherapy, within the CNS including breast and small-cell lung cancer .; primary CNS tumors such as medulloblastoma and glioma .,.; and childhood tumors such as neuroblastoma, retinoblastoma, and rhabdomyosarcoma ..

只看該作者 · 發(fā)表于 2025-3-28 23:47:51

只看該作者 · 發(fā)表于 2025-3-29 06:05:20

只看該作者 · 發(fā)表于 2025-3-29 11:04:37

只看該作者 · 發(fā)表于 2025-3-29 14:42:55

The Viability of Organizations Vol. 1ng. Noncompartmental analysis does not depend on fitting mathematical models to the drug disposition data. Compartmental analysis is the most often used pharmacokinetic modeling approach. This chapter discusses various aspects of compartmental modeling.

只看該作者 · 發(fā)表于 2025-3-29 18:10:35

只看該作者 · 發(fā)表于 2025-3-29 20:10:44

Pharmacokinetic Modeling,ng. Noncompartmental analysis does not depend on fitting mathematical models to the drug disposition data. Compartmental analysis is the most often used pharmacokinetic modeling approach. This chapter discusses various aspects of compartmental modeling.

只看該作者 · 發(fā)表于 2025-3-30 02:59:32

只看該作者 · 發(fā)表于 2025-3-30 04:07:02

2196-9906 ent and validation of bioanalytic methods. The chapters on identifying agents to test in phase III trials and on trial design for the approval of new anticancer agents offer a unique roadmap for moving an agent to NDA submission.978-1-59259-734-5Series ISSN 2196-9906 Series E-ISSN 2196-9914

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 05:06
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved